Want to see CERT full AI Analyst Report?

Certara (CERT) Earnings Dates, Call Summary & Reports

269 Followers

Earnings Data

Report Date

Aug 11, 2026

After Close (Confirmed)

Period Ending

2026 (Q2)

Consensus EPS Forecast

0.1

Last Year’s EPS

0.07

Same Quarter Last Year

Analyst Consensus

Moderate Buy

Based on 10 Analysts Ratings

Earnings Call Summary

Q1 2026

Earnings Call Date:May 11, 2026|

% Change Since:

Earnings Call Sentiment|Neutral

The call presented a mixed but constructive outlook: software performance, strong software bookings, high net retention, regulatory qualifications and strategic AI/partnership initiatives are clear positives that support longer-term growth potential. However, services softness, quarter-to-quarter execution issues, a GAAP net loss and declines in adjusted profitability and EPS are tangible near-term negatives. Management is pursuing structural changes (divestiture, reorg, AI platform and partnerships) to address execution gaps and to reposition the company for scaling, but these actions introduce short-term transition risk.

Company Guidance

Certara updated full‑year 2026 guidance to reported revenue of $395 million to $405 million (including ~$18 million related to the recently divested regulatory/medical‑writing business), which equates to ~0%–4% organic growth excluding the divestiture; management expects first‑half revenue growth nearer the low end of that 0%–4% range with the second half at or above the high end, and a roughly 50/50 software/services revenue mix going forward. They expect full‑year software growth to be at or above the high end of the 0%–4% range (with H1 closer to the midpoint and H2 above the high end) and services growth toward the low end of the 0%–4% range (H1 at/below the low end, improving to the high end in H2); the divested businesses contributed about $13 million in Q1 and ~ $5 million is expected in Q2. Full‑year adjusted EBITDA margin is forecast at 30%–32% (H1 modestly below the range, H2 nearer the high end), adjusted EPS $0.35–$0.41, fully diluted shares 157–159 million, and an effective tax rate of ~30%.

Software Revenue and Bookings Strength

Software revenue of $49.7M in Q1, up 7% year-over-year; software bookings $48.7M, up 20% YoY; trailing 12-month software bookings ~$192.3M, up ~8% YoY.

Healthy Software Retention and Ratable Revenue Mix

Software net retention rate of 106% in the quarter; ratable/subscription revenue represented 57% of software revenue, supporting recurring revenue visibility.

Strategic Divestiture and Capital Return

Closed divestiture of regulatory and medical writing businesses to sharpen focus; businesses had generated ~$50M revenue and ~$17M adjusted EBITDA in 2025. Repurchased ~$82.6M of shares since authorization (including $40M in Q1) and ended Q1 with $149.5M cash.

Regulatory & Scientific Achievements

Simcyp qualified by EMA at a high level after multi-year engagement; PBPK modeling accepted to enable approval of a generic (tazarotene) and supported FDA approval processes (asciminib); Certara scientists published nearly 100 peer-reviewed papers; Pinnacle 21 validated >36 trillion data points supporting >500 approvals.

Product and AI Momentum with Strategic Partnerships

Multiple product releases (D360, Pinnacle 21 enhancements, Phoenix Cloud, Simcyp expansions); creation of AI-native team and appointment of Chief AI Officer; strategic collaborations announced with NVIDIA (accelerated computing/AI) and Altasciences (CRO/CDMO partnership) to scale platform and workflows.

Backlog, TTM Bookings and Second-Half Visibility

Total bookings $115.3M (Q1) and trailing 12-month bookings $479.2M, up 5% YoY; management cites improved deferred revenue and backlog conversion supporting stronger expected second-half performance.

Updated Guidance and Margin Targets

Full-year 2026 revenue guidance of $395M–$405M (0%–4% growth excl. divested business); expectation of full-year adjusted EBITDA margin in the 30%–32% range and adjusted EPS $0.35–$0.41 per share.

Certara (CERT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CERT Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 11, 2026	2026 (Q2)	0.10 / -	0.07	―	―	―
May 11, 2026	2026 (Q1)	0.11 / 0.09	0.14	-35.71% (-0.05)
Feb 26, 2026	2025 (Q4)	0.11 / 0.09	0.15	-40.00% (-0.06)
Nov 06, 2025	2025 (Q3)	0.11 / 0.14	0.13	7.69% (+0.01)
Aug 06, 2025	2025 (Q2)	0.10 / 0.07	0.07	0.00% (0.00)
May 05, 2025	2025 (Q1)	0.11 / 0.14	0.1	40.00% (+0.04)
Feb 26, 2025	2024 (Q4)	0.12 / 0.15	0.09	66.67% (+0.06)
Nov 06, 2024	2024 (Q3)	0.11 / 0.13	0.11	18.18% (+0.02)
Aug 06, 2024	2024 (Q2)	0.10 / 0.07	0.12	-41.67% (-0.05)
May 07, 2024	2024 (Q1)	0.10 / 0.10	0.12	-16.67% (-0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CERT Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 11, 2026	$6.31	$5.13	-18.70%
Feb 26, 2026	$6.59	$6.80	+3.19%
Nov 06, 2025	$11.27	$8.67	-23.07%
Aug 06, 2025	$9.53	$11.26	+18.15%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Certara, Inc. (CERT) report earnings?

Certara, Inc. (CERT) is schdueled to report earning on Aug 11, 2026, After Close (Confirmed).

What is Certara, Inc. (CERT) earnings time?

Certara, Inc. (CERT) earnings time is at Aug 11, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is CERT EPS forecast?

CERT EPS forecast for the fiscal quarter 2026 (Q2) is 0.1.